Hypertension and new treatment approaches targeting the sympathetic nervous system

Current Opinion in Pharmacology

Volumn 21, Issue , 2015, Pages 20-24

  Laffin, Luke J ^a   Bakris, George L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABLATION THERAPY; ADRENERGIC SYSTEM; ARTICLE; BAROREFLEX ACTIVATION THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DRUG TOLERABILITY; ELECTROSTIMULATION THERAPY; FEMORAL ARTERY; FOLLOW UP; GENERATOR POCKET HEMATOMA; GLOMERULUS FILTRATION RATE; HEMATOMA; HUMAN; IMPLANTABLE CAROTID SINUS STIMULATOR; KIDNEY FUNCTION; MORBIDITY; MULTICENTER STUDY (TOPIC); PAIN; PRESSORECEPTOR REFLEX; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL DENERVATION THERAPY; RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; WOUND COMPLICATION; ANIMAL; COMMON CAROTID ARTERY; HYPERTENSION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; SURGERY; SYMPATHECTOMY;

ANIMALS; BAROREFLEX; CAROTID ARTERY, COMMON; HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84919719002     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.12.006     Document Type: Review

References (32)

1. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
2. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
3. P.A. James, S. Oparil, B.L. Carter, W.C. Cushman, C. Dennison-Himmelfarb, and J. Handler 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
4. P. Ruggenenti, A. Schieppati, and G. Remuzzi Progression, remission, regression of chronic renal diseases Lancet 357 2001 1601 1608
5. S.J. Taler Treatment of resistant hypertension Curr Hypertens Rep 7 2005 323 329
6. A. Briasoulis, and G.L. Bakris Timing and efficacy of alternative methods of sympathetic blockade Curr Hypertens Rep 14 2012 455 461
7. G.F. DiBona, and U.C. Kopp Neural control of renal function Physiol Rev 77 1997 75 197
8. M. Esler The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension Exp Physiol 96 2011 611 622
9. H. Krum, M. Schlaich, R. Whitbourn, P.A. Sobotka, J. Sadowski, and K. Bartus Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
10. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Bohm Renal sympathetic denervation in patients with treatment-resistant hypertension (The SYMPLICITY HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
11. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, R. D'Agostino, J.M. Flack, and B.T. Katzen A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
12. T. Mabin, M. Sapoval, V. Cabane, J. Stemmett, and M. Iyer First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension EuroIntervention 8 2012 57 61
13. M.C. Bunte, E. Infante de Oliveira, and M.H. Shishehbor Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon JACC Cardiovasc Interv 6 2013 1 9
14. S.G. Worthley, C.P. Tsioufis, M.I. Worthley, A. Sinhal, D.P. Chew, and I.T. Meredith Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial Eur Heart J 34 2013 2132 2140
15. D. Prochnau, H.R. Figulla, and R. Surber Efficacy of renal denervation with a standard EP catheter in the 24-h ambulatory blood pressure monitoring-long-term follow-up Int J Cardiol 157 2012 447 448
16. D. Prochnau, N. Lucas, H. Kuehnert, H.R. Figulla, and R. Surber Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter EuroIntervention 7 2012 1077 1080
17. C. Ukena, F. Mahfoud, I. Kindermann, C. Barth, M. Lenski, and M. Kindermann Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension J Am Coll Cardiol 58 2011 1176 1182
18. M.D. Esler, M. Bohm, H. Sievert, C.L. Rump, R.E. Schmieder, and H. Krum Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial Eur Heart J 35 2014 1752 1759
19. H. Krum, M.P. Schlaich, P.A. Sobotka, M. Bohm, F. Mahfoud, and K. Rocha-Singh Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the SYMPLICITY HTN-1 study Lancet 383 2014 622 629
20. G.L. Bakris, R.R. Townsend, M. Liu, S.A. Cohen, R. D'Agostino, and J.M. Flack Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3 J Am Coll Cardiol 64 2014 1071 1078
21. P. Eslami, and M. Tuck The role of the sympathetic nervous system in linking obesity with hypertension in white versus black Americans Curr Hypertens Rep 5 2003 269 272
22. N.I. Abate, Y.H. Mansour, M. Tuncel, D. Arbique, B. Chavoshan, and A. Kizilbash Overweight and sympathetic overactivity in black Americans Hypertension 38 2001 379 383
23. D.L. Bhatt, and G.L. Bakris Renal denervation for resistant hypertension N Engl J Med 371 2014 184
24. S. Nathan, and G.L. Bakris The future of renal denervation in resistant hypertension Curr Hypertens Rep 16 2014 494
25. T.E. Lohmeier, D.A. Hildebrandt, S. Warren, P.J. May, and J.T. Cunningham Recent insights into the interactions between the baroreflex and the kidneys in hypertension Am J Physiol Regul Integr Comp Physiol 288 2005 R828 R836
26. A. Briasoulis, and G. Bakris Efficacy of baroreflex activation therapy for the treatment of resistant hypertension EuroIntervention 9 2013 R136 R139
27. U.C. Hoppe, M.C. Brandt, R. Wachter, J. Beige, L.C. Rump, and A.A. Kroon Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial J Am Soc Hypertens 6 2012 270 276
28. I.J. Scheffers, A.A. Kroon, J. Schmidli, J. Jordan, J.J. Tordoir, and M.G. Mohaupt Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study J Am Coll Cardiol 56 2010 1254 1258
29. E.G. Lovett, J. Schafer, and C.L. Kaufman Chronic baroreflex activation by the Rheos system: an overview of results from European and North American feasibility studies Conf Proc IEEE Eng Med Biol Soc 2009 2009 4626 4630
30. J.D. Bisognano, G. Bakris, M.K. Nadim, L. Sanchez, A.A. Kroon, and J. Schafer Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial J Am Coll Cardiol 58 2011 765 773
31. G.L. Bakris, M.K. Nadim, H. Haller, E.G. Lovett, J.E. Schafer, and J.D. Bisognano Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial J Am Soc Hypertens 6 2012 152 158
32. R. Iliescu, I. Tudorancea, and T.E. Lohmeier Baroreflex activation: from mechanisms to therapy for cardiovascular disease Curr Hypertens Rep 16 2014 453